NCT02485340View on ClinicalTrials.gov

The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Migraine
Interventions
DRUG

5-ISMN (isosorbide-5-mononitrate)

5-ISMN is given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

DRUG

Sumatriptan

5-ISMN is given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

DRUG

Placebo

5-ISMN is given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

Trial Locations (1)

2600

Emma Katrine Hansen, Copenhagen

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT02485340 - The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache | Biotech Hunter | Biotech Hunter